Skip to main content
Grifols S.A. logo

Grifols S.A. — Investor Relations & Filings

Ticker · GRF ISIN · ES0171996087 LEI · 959800HSSNXWRKBK4N60 MC Manufacturing
Filings indexed 684 across all filing types
Latest filing 2026-05-15 Foreign Filer Report
Country ES Spain
Listing MC GRF

About Grifols S.A.

https://www.grifols.com/en/home

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Recent filings

Filing Released Lang Actions
FORM 6-K
Foreign Filer Report
2026-05-15 English
Convocatoria de la Junta General Ordinaria 2026 de Grifols, S.A.
Proxy Solicitation & Information Statement Classification · 85% confidence The document is the formal notice (“convocatoria”) of the Annual General Meeting of Grifols, S.A., including the agenda, proposals, right to information, voting instructions, and proxy forms. It serves as the proxy solicitation/information statement sent to shareholders to request their votes. This aligns with the definition of a Proxy Solicitation & Information Statement.
2026-05-15 Spanish
Convocatoria de la Junta General Ordinaria 2026 de Grifols, S.A.
Proxy Solicitation & Information Statement Classification · 94% confidence The document is the formal convocation notice for the Ordinary General Shareholders’ Meeting (Junta General Ordinaria), including the detailed agenda, proposals for approval, shareholder rights, proxy and voting instructions, and related materials. It is clearly a set of materials sent to shareholders to inform them of the meeting and solicit their votes. This corresponds to the Proxy Solicitation & Information Statement category (PSI).
2026-05-15 Spanish
6-K - Grifols SA (0001438569) (Filer)
Foreign Filer Report
2026-05-07 English
Grifols anuncia la información financiera del primer trimestre de 2026
Regulatory Filings
2026-05-07 Spanish
20-F - Grifols SA (0001438569) (Filer)
Annual Report
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.